Maor Shlomo

Israeli tech entrepreneur Maor Shlomo, who sold Base44 to Wix for $80 million, launched the Second Light fund to invest in cancer research. Shlomo discusses how artificial intelligence is transforming medical discovery, the challenges of biological validation, and the future of healthcare.

PR expert Rani Rahav was not indifferent to the story of high-tech entrepreneur Maor Shlomo, who sold his company Base44 to Wix for $80 million after about 400 days of reserve duty. What caused Rahav to publicly salute him, and what does the entrepreneur think about academic studies?

Maor Shlomo is the new face of Israeli high-tech: a solo founder who achieved an $80 million exit in just six months. In a candid interview, he discusses sleepless nights, his skepticism toward academic degrees, the tragic loss of his mother, and his mission to use AI to fight cancer.

Maor Shlomo, founder of Base44, which was sold to Wix for $80 million, explains how he believes artificial intelligence is changing the job market and what young people should do.

Yuval Shlomo, wife of Base44 founder Maor Shlomo, discusses her transition from the tattoo industry to the high-tech world. She has taken on a marketing and community management role at Base4u Solutions, which leverages Base44 technology to build business management systems.

Maor Shlomo, the founder of BASE44, has announced the establishment of a private fund to invest in startups developing cancer treatments. The decision follows the personal loss of his mother to the disease.